Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0161
NEWS & VIEWS
|
Aggressiveness and Complexity of Pancreatic Cancer: Research focused on tumorigenesis-based prevention or metastasis-based treatment?
|
|
Affiliation: Prof. Dr.med. Ernst Hanisch, Chefarzt und Ärztlicher Direktor, Klinik für Allgemein- Viszeral- und Endokrine Chirurgie, Asklepios Klinik Langen, Akademisches Lehrkrankenhaus der JWG-Universität Frankfurt, Röntgenstr 20, 63225 Langen .
Tel: 06103/912 61200; FAX: 06103/9121814,
Email: E.Hanisch@Asklepios.com |
Since there is no abstract available we provide the first paragraph
The overall 5-year mortality rate of adenocarcinoma of pancreas is 97% despite advances with surgery, chemotherapy, radiotherapy and more recently targeted treatment. The perspectives of improving cure rates, given the updated cancer genomes advances, are limited. Therefore, latest systematic pancreatic cancer exome sequencing is exploring the potential of mutations-based risk prediction and prevention. Which are the challenges and promises of this emerging research direction?
(Citation: Gastric & Breast Cancer 2010; 10(2): 91-93)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €33 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
